2-Chloro-4-(1-dibenzofuranyl)-6-phenyl-1,3,5-triazine – (1883265-32-4)

1855006-12-0, 4-(3-fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)-N-methylpicolinamide, Regorafenib Dipyrimidine, RV6UQ6V2Q5, 4-[2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yl]oxyanilino]-N-methylpyridine-2-carboxamide, 4-(3-Fluoro-4-((2-(methylcarbamoyl)pyridin-4-yl)amino)phenoxy)-N-methylpyridine-2-carboxamide, Regorafenib Dipyrimidine 2-Pyridinecarboxamide, 4-[3-fluoro-4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-N-methyl- -[3-Fluoro-4-[[2-[(methylamino)carbonyl]-4-pyridinyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide 4-[3-Fluoro-4-[[2-(methylcarbamoyl)pyridin-4-yl]amin, Regorafenib monohydrate impurity C [EP], UNII-RV6UQ6V2Q5, SCHEMBL2560625, CS-M2814, FZC00612, D77494, REGORAFENIB MONOHYDRATE IMPURITY C [EP IMPURITY]